# Headlands Research

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/headlands-research

- Industry: Pharmaceuticals
- Headquarters: Lake Worth, US
- Website: www.headlandsresearch.com
- Latest round: Series A (Jan 6, 2018)
- Investors on record: 1

## About

Headlands Research, Inc. is a U.S.-based integrated clinical trial site organization dedicated to advancing innovative medical therapies through highly efficient and inclusive clinical trial operations. Founded in 2018 in Mill Valley, US, Headlands Research, Inc. focuses on conducting clinical trials for medical advancements. The company is led by CEO Blake Torrence, who has a history of involvement in clinical research. In August 2025, Thomas H. Lee Partners agreed to acquire a majority stake in Headlands Research, Inc. from KKR for approximately USD 600 million. Headlands Research operates as a multinational integrated clinical trial site organization, primarily focused on conducting clinical trials that advance innovative medical therapies. Its core offerings encompass extensive site databases and physician partnerships, aimed at facilitating large-volume recruitment and retention of diverse and inclusive populations for clinical studies. By leveraging a network of experienced principal investigators and clinical research professionals, Headlands Research provides operational excellence and high-quality data across a broad range of therapeutic areas, including central nervous system (CNS) disorders, mental health, and vaccines. The company serves a wide client base, including pharmaceutical companies, biotechnology firms, and contract research organizations (CROs), operating across multiple geographical markets in North America, Europe, and Asia. Headlands Research’s commitment to diversity and inclusivity ensures a rich participant experience while addressing the complex needs of diverse populations enrolled in clinical trials.Headlands Research generates revenue primarily through partnerships with pharmaceutical companies, biotechnology firms, and contract research organizations that engage its services for conducting clinical trials. The transaction structure typically involves B2B collaborations, where clients contract Headlands Research to deliver clinical trial services, encompassing participant recruitment, trial management, and data collection. Revenue streams are derived from service agreements that outline specific deliverables, timelines, and performance metrics. While specific pricing plans for services are proprietary, they are determined based on the complexity and duration of each clinical trial project. Headlands Research's extensive capabilities in managing large-scale trials and its rigorous approach to participant care contribute to its standing as a trusted partner in advancing medical research initiatives. The August 2025 acquisition aims to expand Headlands Research, Inc.'s reach, invest in technology and centralized infrastructure, and enhance its capabilities.

## Funding rounds

- Series A, Jan 6, 2018 — KKR

## Investors

- KKR (https://capitalatlas.ai/funds/kkr) — Series A